Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic leflunomide 20 mg vs Arava in healthy Thai male volunteers under fasting
TCTR20210215001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of leflunomide (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Planned start May 2021; status: not yet recruiting.
02
Drugs
leflunomide
Beyond the preview
Go deeper on TCTR20210215001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210215001.